A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Trial Details

NCT ID

NCT06234423

Phase

PHASE1

Sponsor

OnCusp Therapeutics, Inc.

Status

RECRUITING

Cancer Type

Ovarian Cancer

Interventions

• CUSP06

Locations (sample)

• Denver, Colorado, United States|39.73915,-104.9847
• New Haven, Connecticut, United States|41.30815,-72.92816
• Miami Beach, Florida, United States|25.79065,-80.13005
• Sarasota, Florida, United States|27.33643,-82.53065
• Boston, Massachusetts, United States|42.35843,-71.05977

Key Eligibility Criteria

• Written informed consent provided prior to any screening procedures.
• Male or female patients, ≥18 years of age at the time of obtaining informed consent.
• Patients with histologically or cytologically confirmed advanced solid tumors previously treated with standard of care systemic therapy, or for who…
• Willingness to provide archival tumor tissue, when available. If no archival tissue is available, willingness to undergo a pretreatment biopsy if m…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.